Complete response of a metastatic gastroesophageal adenocarcinoma on irinotecan-based chemotherapy in a dialysis patient | Zendy

F. Geurs | Zendy; BULTE | Zendy

Open Access

Complete response of a metastatic gastroesophageal adenocarcinoma on irinotecan-based chemotherapy in a dialysis patient

Author(s) -

F. Geurs,

BULTE

Publication year - 2010

Publication title -

international journal of nephrology and renovascular disease

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.846

H-Index - 27

ISSN - 1178-7058

DOI - 10.2147/ijnrd.s7650

Subject(s) - irinotecan , medicine , chemotherapy , adenocarcinoma , dialysis , hemodialysis , oncology , cancer , combination chemotherapy , colorectal cancer

We present the first case report of a complete response of metastatic gastroesophageal cancer in a chronic hemodialysis patient with irinotecan-based chemotherapy. An elderly dialysis patient presented with diffuse liver metastases by a gastroesophageal adenocarcinoma. He received combination chemotherapy with 5 fluorouracil and irinotecan. After six months of chemotherapy, liver scans show complete remission. The principles, practice, and experience of chemotherapy with irinotecan during dialysis are discussed.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research